Adaptimmune Therapeutics plc (ADAP): Price and Financial Metrics

Adaptimmune Therapeutics plc (ADAP): $0.58

0.00 (-0.41%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

B

Add ADAP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#31 of 337

in industry

ADAP Price/Volume Stats

Current price $0.58 52-week high $2.05
Prev. close $0.58 52-week low $0.53
Day low $0.55 Volume 434,500
Day high $0.58 Avg. volume 1,031,203
50-day MA $0.61 Dividend yield N/A
200-day MA $0.91 Market Cap 147.52M

ADAP Stock Price Chart Interactive Chart >


Adaptimmune Therapeutics plc (ADAP) Company Bio


Adaptimmune Therapeutics plc is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its T-cell receptor platform. The company was founded in 2014 and is based in Abingdon, the United Kingdom.


ADAP Latest News Stream


Event/Time News Detail
Loading, please wait...

ADAP Latest Social Stream


Loading social stream, please wait...

View Full ADAP Social Stream

ADAP Price Returns

1-mo -1.68%
3-mo -1.13%
6-mo -46.30%
1-year -54.69%
3-year -81.29%
5-year -85.57%
YTD 7.67%
2024 -32.07%
2023 -45.68%
2022 -61.07%
2021 -30.43%
2020 349.17%

Continue Researching ADAP

Here are a few links from around the web to help you further your research on Adaptimmune Therapeutics PLC's stock as an investment opportunity:

Adaptimmune Therapeutics PLC (ADAP) Stock Price | Nasdaq
Adaptimmune Therapeutics PLC (ADAP) Stock Quote, History and News - Yahoo Finance
Adaptimmune Therapeutics PLC (ADAP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!